MedTrace Logo

Comparison of Two Dosages of Heparin Before Extracorporeal Circulation

NCT03752437 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-02-15

No results posted yet for this study

Summary

In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery.

Conditions

  • Extracorporeal Circulation; Complications

Interventions

DIAGNOSTIC_TEST

ACT (Activated Clotting Time)

Measure of ACT in the two arms in order to determine if injection of heparin based on ideal weight is better or not than those one on real weight.

DRUG

Heparin

300 IU of heparin

Sponsors & Collaborators

  • Astes

    lead OTHER

Principal Investigators

  • Eric Deflandre, MD, PhD · Astes

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03752437 on ClinicalTrials.gov